slotkoers
Korea S.E.
00:00:00 13-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
1.926
KRW
|
-0,57%
|
|
-0,62%
|
+2,12%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
39.160
|
324.844
|
571.042
|
456.449
|
239.924
|
Bedrijfswaarde
1 |
32.012
|
313.748
|
376.093
|
140.601
|
-2.858
|
K/w-verhouding
|
-31,6
x
|
14,8
x
|
3,78
x
|
2,55
x
|
-4,33
x
|
Dividendrendement
|
-
|
-
|
1,2%
|
-
|
-
|
Marktkapitalisatie/omzet
|
4,28
x
|
7,11
x
|
1,77
x
|
0,97
x
|
17,4
x
|
Bedrijfswaarde/omzet
|
3,5
x
|
6,86
x
|
1,17
x
|
0,3
x
|
-0,21
x
|
Bedrijfswaarde/EBITDA
|
-114
x
|
12
x
|
1,92
x
|
0,64
x
|
0,06
x
|
Bedrijfswaarde/FCF
|
-
|
-23.232.133
x
|
2.409.823
x
|
1.175.824
x
|
31.837
x
|
FCF Yield
|
-
|
-0%
|
0%
|
0%
|
0%
|
Price to Book
|
2,57
x
|
6,67
x
|
2,83
x
|
1,32
x
|
0,84
x
|
Aantal aandelen (in duizenden)
|
112.692
|
136.776
|
136.776
|
128.126
|
127.213
|
Referentieprijs
2 |
347,5
|
2.375
|
4.175
|
3.562
|
1.886
|
Datum van publicatie
|
17-03-21
|
17-03-21
|
25-02-22
|
09-03-23
|
15-03-24
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
9.151
|
45.717
|
321.829
|
471.273
|
13.827
|
EBITDA
1 |
-280,2
|
26.117
|
195.576
|
219.569
|
-47.632
|
Bedrijfsresultaat (EBIT)
1 |
-875,3
|
25.358
|
193.593
|
214.722
|
-52.355
|
Operationele Marge
|
-9,57%
|
55,47%
|
60,15%
|
45,56%
|
-378,63%
|
Resultaat voor belastingen (EBT)
1 |
-1.226
|
20.962
|
196.727
|
237.557
|
-62.180
|
Nettowinst (verlies)
1 |
-1.226
|
20.937
|
151.205
|
182.627
|
-55.424
|
Nettomarge
|
-13,4%
|
45,8%
|
46,98%
|
38,75%
|
-400,83%
|
WPA
2 |
-11,00
|
160,7
|
1.105
|
1.395
|
-435,5
|
Free Cash Flow
|
-
|
-13.505
|
156.066
|
119.577
|
-89.768
|
FCF-marge
|
-
|
-29,54%
|
48,49%
|
25,37%
|
-649,21%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
79,8%
|
54,46%
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
103,22%
|
65,48%
|
-
|
Dividend per aandeel
|
-
|
-
|
50,00
|
-
|
-
|
Datum van publicatie
|
17-03-21
|
17-03-21
|
25-02-22
|
09-03-23
|
15-03-24
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
7.148
|
11.096
|
194.949
|
315.847
|
242.782
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-13.505
|
156.066
|
119.577
|
-89.768
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
65,5%
|
121%
|
66,6%
|
-17,5%
|
ROA (netto-inkomsten/totale activa)
|
-
|
30,3%
|
59,2%
|
33,2%
|
-8,03%
|
Totale activa
1 |
-
|
69.154
|
255.509
|
549.951
|
690.096
|
Nettoactief per aandeel
2 |
135,0
|
356,0
|
1.477
|
2.706
|
2.259
|
Cashflow per aandeel
2 |
33,70
|
105,0
|
1.291
|
153,0
|
96,70
|
Capex
1 |
2.987
|
15.081
|
18.061
|
44.510
|
22.204
|
Capex/omzet
|
32,64%
|
32,99%
|
5,61%
|
9,44%
|
160,58%
|
Datum van publicatie
|
17-03-21
|
17-03-21
|
25-02-22
|
09-03-23
|
15-03-24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +2,12% | 179 mln. | | -3,58% | 12,37 mld. | | -1,48% | 8,37 mld. | | +8,70% | 5,84 mld. | | +25,61% | 5,4 mld. | | -4,58% | 4,37 mld. | | -51,80% | 3,23 mld. | | +16,25% | 2,8 mld. | | +30,25% | 2,26 mld. | | -4,08% | 1,87 mld. |
Diagnostische en teststoffen
|